TIDMBMK
RNS Number : 6659V
Benchmark Holdings PLC
06 November 2017
Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")
REPLACEMENT: Appointment of Non-Executive Directors
The following corrections have been made to the "Appointment of
Non-Executive Directors" announcement released this morning at
0700h (RNS 5754V):
It was erroneously stated that Nova Austral is owned by Cargill,
and it should have stated that it is owned by Altor and Bain.
The full amended text is shown below.
Appointment of Non-Executive Directors
Benchmark strengthens the board bringing in leading industry and
commercial expertise
Benchmark, the aquaculture biotechnology and food chain
sustainability business, announces the appointment of Hugo Wahnish
and Yngve Myhre as Non-Executive Directors of the Company with
immediate effect.
Hugo Wahnish (65) has over 35 years of experience in the animal
health and pharmaceuticals industry, firstly with GlaxoSmithKline,
and more recently with Merck during a period of major growth in the
organisation. Hugo held the post of Chief Commercial Officer Animal
Health at Merck, having responsibility for Merck's commercial
operations worldwide. Since stepping down from that role in 2012,
Hugo has acted as an independent senior advisor with several
multinational companies, private equity groups and consulting firms
primarily in the animal health sector. Hugo brings a wealth of
international experience to the board of Benchmark, alongside his
expertise in aggressively growing businesses and in the
commercialisation of medicines and animal health products. Hugo is
based in the United States.
Yngve Myhre (48) has more than 20 years experience in the
aquaculture sector as a senior executive, adviser and investor.
Yngve was chief executive of leading Norwegian salmon producer
Salmar, and of international white fish supplier Aker Seafood
during periods of successful growth. He is now chairman of Chilean
salmon producer Nova Austral, owned by Altor and Bain, and sits on
the boards of Mediterranean fish producer Andromeda and Norwegian
aquaculture research institute Nofima. Yngve also acts as strategic
adviser to investors in the aquaculture sector. Yngve has a very
strong track record in Benchmark's focus area of aquaculture, both
in the Norwegian and international markets. Yngve is based in
Norway.
Information in respect of Hugo Wahnish and Yngve Myhre, as
required by Rule 17 and Schedule 2(g) of the AIM Rules for
Companies, is set out below.
Benchmark's Chairman, Alex Hambro, commented:
"We are delighted to welcome Hugo and Yngve to the Board of
Benchmark. Their combined expertise and experience in the
aquaculture and pharmaceutical industries will broaden the Board of
Benchmark as the Company seeks to maximise value from its unique
portfolio of products and technologies.
The Board of Benchmark carried out an extensive international
search to bring to the Board additional leading international
industry and commercialisation expertise. Attracting Hugo and Yngve
is a testament of the strength of our industry standing, our
technology platform and our potential."
Additional information:
Neither Hugo Wahnish nor Yngve Myhre hold any shares in the
Company.
Hugo Wahnish's current directorships/partnerships:
Dinicola Partners
Maxima LLC
Yngve Myhre's current directorships/partnerships:
Rosøy AS
Nova Austral SA
Nova Austral Management Invest AS
Blåfjell AS
Blåfjell Holding
Aqua Site AS
Aqua Site Holding
Perseus Seafood Limited
Helgeland Adventure AS
Yngve Myhre's past directorships/partnerships (last 5
years):
SalMar ASA
Albain Midco Norway AS (EWOS Group)
Arnarlax and Kvitholmen AS
Trænafestivalen
There is no further information to be disclosed pursuant to AIM
Rule 17 and Schedule 2(g) of the AIM Rules for Companies.
- Ends -
For further information, please contact:
Benchmark Holdings plc Tel: 020 7920 3150
Malcolm Pye, CEO
Ivonne Cantu, Investor Relations Director
Rachel Aninakwah, Communications
Numis Tel: 020 7260 1000
Michael Meade / Freddie Barnfield (NOMAD)
James Black (Corporate Broking)
Tavistock Tel: 020 7920 3150
Sophie Praill
Notes to Editors:
Benchmark challenges the status quo in aquaculture.
Since 2000, Benchmark has consistently worked to build a
platform to serve its customers, helping food producers take
control of their biological environment through the combination of
genetics, nutrition, health and knowledge services. Through its
in-depth knowledge of animal biology Benchmark is able to tackle
the key issues facing producers primarily in the aquaculture
sector.
The Company has proven distribution capabilities in high growth
markets and operates internationally with R&D facilities,
commercial farms, diagnostic laboratories, manufacturing sites,
production facilities and commercial offices across 27 countries in
five continents. As at 30 September 2017, Benchmark employed 952
people.
For further information on Benchmark please visit
www.benchmarkplc.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAEAAFKEFXXFFF
(END) Dow Jones Newswires
November 06, 2017 07:20 ET (12:20 GMT)
Benchmark (LSE:BMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Benchmark (LSE:BMK)
Historical Stock Chart
From Apr 2023 to Apr 2024